{"id":"NCT01484652","sponsor":"Mallinckrodt","briefTitle":"Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension","officialTitle":"A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of the Safety and Analgesic Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain Followed by an Open-Label Extension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2012-08","completion":"2012-09","firstPosted":"2011-12-02","resultsPosted":"2014-07-02","lastUpdate":"2016-10-21"},"enrollment":329,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative","Bunion"],"interventions":[{"type":"DRUG","name":"COV795","otherNames":["MNK795"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"COV795","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to show the effectiveness of repeated doses of COV795 versus placebo, using the summed pain intensity difference over the first 48 hours in subjects with acute moderate to severe pain following bunionectomy.","primaryOutcome":{"measure":"SPID48 (Summed Pain Intensity Difference)","timeFrame":"48 hours","effectByArm":[{"arm":"COV795","deltaMin":114.9,"sd":7.64},{"arm":"Placebo","deltaMin":66.9,"sd":7.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["United States"]},"refs":{"pmids":["25157951","24351079"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":235},"commonTop":["Nausea","Dizziness","Headache","Vomiting","Constipation"]}}